Molecular Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025


#186979

164pages

Transparency

$ 5795

In Stock

Global Molecular Diagnostics Market: Overview

This report on the molecular diagnostics market studies the current and future prospects of the market globally. Growing incidences of chronic infectious diseases such as tuberculosis, HIV/AIDS, diarrhea, pneumonia hepatitis, in addition to increasing geriatric population, and rising number of biotechnology companies is expected to accentuate the growth of global molecular diagnostics market. The global molecular diagnostics market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments and sub-segments of the market. It also provides information and data analysis of the global molecular diagnostics market with respect to market segments based on technology, application, end user and their geographic analysis. 

Global Molecular Diagnostics Market: Segmentation

Based on technology, the molecular diagnostics market has been segmented into six major categories: PCR and real-time PCR, hybridization, microarray, transcription-mediated amplification, next-generation sequencing and others which includes mass spectrometry etc. These are the major techniques which are used in molecular diagnostics for diagnosis of disease. Likewise, on the basis of application, the global molecular diagnostics market has been segmented into infectious diseases, oncology, blood screening, microbiology, genetic testing and women’s health. Infectious disease testing has been segmented into two major categories, namely, virology and bacteriology. The market segments have been extensively analyzed based on usefulness, adoption, efficacy, revenue, and geographical coverage. The market size and forecast in terms of US$ Mn for each segment has been provided for the period from 2015 to 2025. The molecular diagnostics market report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2015 as the base year. A brief patient pool analysis by infectious disease, cancer and cardiovascular disease have also been discussed in the global molecular diagnostics report. 

Based on End User the global molecular diagnostics market is segmented as hospitals, diagnostic laboratories, blood banks, academics & research and others. The market size and forecast for each of these end user has been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2015 as the base year. 

Global Molecular Diagnostics Market: Regional Outlook

Geographically, the molecular diagnostics market in Europe has been categorized into five major regions:   North America, Europe, Asia Pacific, Latin America and Middle East & Africa. The market size and forecast for each of these regions has been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2015 as the base year. The research study also covers the competitive scenario in these regions. A detailed qualitative analysis of factors responsible for driving that is supply side driver, demand side driver and economic driver, restraining the growth of the market and future opportunities has been provided in the market overview section. This section of the report also provides market attractiveness analysis, Porter’s Five Forces analysis, and market share analysis by key players, competitive matrix thus presenting a thorough analysis of the overall competitive scenario in the global molecular diagnostics market. 

Key Players Mentioned in this Report are:

Current and future trends has also been provided for new entrants as well as existing market players to assist them in taking strategic initiatives to establish a strong presence in the market. The report also profiles major players in the global molecular diagnostics market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments, SWOT analysis. Major players profiled in this report include F. Hoffmann-La Roche Ltd., Abbott Laboratories, QIAGEN N.V. ,bioMérieux SA, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Danaher Corporation, Siemens AG and Thermo Fisher Scientific Inc., and others.

The global molecular diagnostics market is segmented as given below:

Global Molecular Diagnostics Market, by Technology

  • PCR and Real-Time PCR
  • Hybridization
  • Microarray
  • Transcription-Mediated Amplification
  • Next-Generation Sequencing
  • Others (Mass Spectrometry, etc.)

Global Molecular Diagnostics Market, by Application

  • Infectious Diseases
  • Oncology
  • Blood Screening
  • Microbiology
  • Genetic Testing
  • Women’s Health

Global Molecular Diagnostics Market, by End Use

  • Hospitals
  • Diagnostic Laboratories
  • Blood Banks
  • Academics
  • Research

Global Molecular Diagnostics Market, by Region

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • Australia
  • India
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

 

Table of Content

1. Preface
1.1. Market definition and scope
1.2. Market segmentation
1.3. Key research objectives
1.4. Research highlights

2. Assumptions and research methodology

3. Executive summary: global molecular diagnostics market

4. Market overview
4.1. Introduction
4.1.1. Product definition
4.2. Market dynamics
4.2.1. Drivers
4.2.1.1. Economic drivers
4.2.1.2. Supply side drivers
4.2.1.3. Demand side drivers
4.2.2. Restraints
4.2.3. Opportunities

5. Global Molecular Diagnostics Market Analysis and Forecast, 2017-2025
5.1. Market Revenue Projections (US$ Mn)
5.2. Porter’s Five forces Analysis: Global Molecular Diagnostics Market
5.3. Future Market Outlook

6. Global Molecular Diagnostics Market Analysis and Forecast, By Technology
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Key Trends
6.4. Market Value (US$ Mn) Forecast By Technology
6.4.1. PCR and Real-Time PCR
6.4.2. Hybridization
6.4.3. Microarray
6.4.4. Transcription-Mediated Amplification
6.4.5. Next-Generation Sequencing
6.4.6. Others (Mass Spectrometry etc.)
6.5. Market Attractiveness By Technology

7. Global Molecular Diagnostics Market Analysis and Forecast, By Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Key Trends
7.4. Market Value (US$ Mn) Forecast By Application
7.4.1. Infectious Diseases
7.4.1.1. Virology 
7.4.1.2. Bacteriology
7.4.2. Oncology
7.4.3. Blood Screening
7.4.4. Microbiology
7.4.5. Genetic Testing
7.4.6. Women’s Health
7.5. Market Attractiveness By Application

8. Global Molecular Diagnostics Market Analysis and Forecasts, By End User
8.1. Key Findings
8.2. Policies and Regulations
8.3. Market Value (US$ Mn) Forecast By End User
8.3.1. Hospitals
8.3.2. Diagnostics Laboratories
8.3.3. Blood Banks
8.3.4. Academics & Research
8.3.5. Others
8.4. Market Attractiveness By End User

9. Global Molecular Diagnostics Market Analysis and Forecasts, By Region
9.1. Key Findings
9.2. Policies and Regulations
9.3. Market Value (US$ Mn) Forecast By Region
9.3.1. North America
9.3.2. Europe
9.3.3. Asia Pacific
9.3.4. Latin America
9.3.5. Middle East and Africa
9.4. Market Attractiveness By Region

10. North America Molecular Diagnostics Market Analysis and Forecast
10.1. Key Findings
10.2. Policies and Regulations
10.3. Key Trends
10.4. Market Value (US$ Mn) Forecast By Technology
10.4.1. PCR and Real-Time PCR
10.4.2. Hybridization
10.4.3. Microarray
10.4.4. Transcription-Mediated Amplification
10.4.5. Next-Generation Sequencing
10.4.6. Others (Mass Spectrometry etc.)
10.5. Market Value (US$ Mn) and Forecast By Application
10.5.1. Infectious Diseases
10.5.1.1. Virology 
10.5.1.2. Bacteriology
10.5.2. Oncology
10.5.3. Blood Screening
10.5.4. Microbiology
10.5.5. Genetic Testing
10.5.6. Women’s Health
10.6. Market Value (US$ Mn) Forecast By End User
10.6.1. Hospitals
10.6.2. Diagnostics Laboratories
10.6.3. Blood Banks
10.6.4. Academics & Research
10.6.5. Others
10.7. Market Value (US$ Mn) Forecast By Country
10.7.1. U.S.
10.7.2. Canada
10.8. Market Attractiveness Analysis 
10.8.1. By Technology
10.8.2. By Application
10.8.3. By End User
10.8.4. By Country

11. Europe Molecular Diagnostics Market Analysis and Forecast
11.1. Key Findings
11.2. Policies and Regulations
11.3. Key Trends
11.4. Market Value (US$ Mn) Forecast By Technology
11.4.1. PCR and Real-Time PCR
11.4.2. Hybridization
11.4.3. Microarray
11.4.4. Transcription-Mediated Amplification
11.4.5. Next-Generation Sequencing
11.4.6. Others (Mass Spectrometry etc.)
11.5. Market Value (US$ Mn) Forecast By Application
11.5.1. Infectious Diseases
11.5.1.1. Virology 
11.5.1.2. Bacteriology
11.5.2. Oncology
11.5.3. Blood Screening
11.5.4. Microbiology
11.5.5. Genetic Testing
11.5.6. Women’s Health
11.6. Market Value (US$ Mn) Forecast By End User
11.6.1. Hospitals
11.6.2. Diagnostics Laboratories
11.6.3. Blood Banks
11.6.4. Academics & Research
11.6.5. Others
11.7. Market Value (US$ Mn) Forecast By Country
11.7.1. Germany
11.7.2. France
11.7.3. U.K.
11.7.4. Italy
11.7.5. Spain
11.7.6. Rest of Europe
11.8. Market Attractiveness Analysis 
11.8.1. By Technology
11.8.2. By Application
11.8.3. By End User
11.8.4. By Country

12. Asia Pacific Molecular Diagnostics Market Analysis and Forecast
12.1. Key Findings
12.2. Policies and Regulations
12.3. Key Trends
12.4. Market Value (US$ Mn) Forecast By Technology
12.4.1. PCR and Real-Time PCR
12.4.2. Hybridization
12.4.3. Microarray
12.4.4. Transcription-Mediated Amplification
12.4.5. Next-Generation Sequencing
12.4.6. Others (Mass Spectrometry etc.)
12.5. Market Value (US$ Mn) Forecast By Application
12.5.1. Infectious Diseases
12.5.1.1. Virology 
12.5.1.2. Bacteriology
12.5.2. Oncology
12.5.3. Blood Screening
12.5.4. Microbiology
12.5.5. Genetic Testing
12.5.6. Women’s Health
12.6. Market Value (US$ Mn) Forecast By End User
12.6.1. Hospitals
12.6.2. Diagnostics Laboratories
12.6.3. Blood Banks
12.6.4. Academics & Research
12.6.5. Others
12.7. Market Value (US$ Mn) Forecast By Country
12.7.1. China
12.7.2. Japan
12.7.3. Australia
12.7.4. India
12.7.5. Rest of Asia Pacific
12.8. Market Attractiveness Analysis 
12.8.1. By Technology
12.8.2. By Application
12.8.3. By End User
12.8.4. By Country

13. Latin America Molecular Diagnostics Market Analysis and Forecast
13.1. Key Findings
13.2. Policies and Regulations
13.3. Key Trends
13.4. Market Value (US$ Mn) Forecast By Technology
13.4.1. PCR and Real-Time PCR
13.4.2. Hybridization
13.4.3. Microarray
13.4.4. Transcription-Mediated Amplification
13.4.5. Next-Generation Sequencing
13.4.6. Others (Mass Spectrometry etc.)
13.5. Market Value (US$ Mn) Forecast By Application
13.5.1. Infectious Diseases
13.5.1.1. Virology 
13.5.1.2. Bacteriology
13.5.2. Oncology
13.5.3. Blood Screening
13.5.4. Microbiology
13.5.5. Genetic Testing
13.5.6. Women’s Health
13.6. Market Value (US$ Mn) Forecast By End User
13.6.1. Hospitals
13.6.2. Diagnostics Laboratories
13.6.3. Blood Banks
13.6.4. Academics & Research
13.6.5. Others
13.7. Market Value (US$ Mn) Forecast By Country
13.7.1. Brazil
13.7.2. Mexico
13.7.3. Rest of Latin America
13.8. Market Attractiveness Analysis 
13.8.1. By Technology
13.8.2. By Application
13.8.3. By End User
13.8.4. By Country

14. Middle East and Africa Molecular Diagnostics Market Analysis and Forecast
14.1. Key Findings
14.2. Policies and Regulations
14.3. Key Trends
14.4. Market Value (US$ Mn) Forecast By Technology
14.4.1. PCR and Real-Time PCR
14.4.2. Hybridization
14.4.3. Microarray
14.4.4. Transcription-Mediated Amplification
14.4.5. Next-Generation Sequencing
14.4.6. Others (Mass Spectrometry etc.)
14.5. Market Value (US$ Mn) Forecast By Application
14.5.1. Infectious Diseases
14.5.1.1. Virology 
14.5.1.2. Bacteriology
14.5.2. Oncology
14.5.3. Blood Screening
14.5.4. Microbiology
14.5.5. Genetic Testing
14.5.6. Women’s Health
14.6. Market Value (US$ Mn) Forecast By End User
14.6.1. Hospitals
14.6.2. Diagnostics Laboratories
14.6.3. Blood Banks
14.6.4. Academics & Research
14.6.5. Others
14.7. Market Value (US$ Mn) Forecast By Country
14.7.1. Saudi Arabia
14.7.2. South Africa
14.7.3. Rest of MEA
14.8. Market Attractiveness Analysis 
14.8.1. By Technology
14.8.2. By Application
14.8.3. By End User
14.8.4. By Country

15. Competition Landscape
15.1. Market Player – Competition Matrix (By Tier and Size of companies)
15.2. Market Share Analysis By Company (2015)
15.3. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
15.3.1. Abbott Laboratories
15.3.1.1 Company Overview
15.3.1.2 Business Overview
15.3.1.3 Financial Overview
15.3.1.4 SWOT Analysis
15.3.1.5 Strategic Overview
15.3.2. Becton, Dickinson and Company
15.3.2.1 Company Overview
15.3.2.2 Business Overview
15.3.2.3 Financial Overview
15.3.2.4 SWOT Analysis
15.3.2.5 Strategic Overview
15.3.3. Bio-Rad Laboratories, Inc.
15.3.3.1 Company Overview
15.3.3.2 Business Overview
15.3.3.3 Financial Overview
15.3.3.4 SWOT Analysis
15.3.3.5 Strategic Overview
15.3.4. BioMérieux SA
15.3.4.1 Company Overview
15.3.4.2 Business Overview
15.3.4.3 Financial Overview
15.3.4.4 SWOT Analysis
15.3.4.5 Strategic Overview
15.3.5. Danaher Corporation
15.3.5.1 Company Overview
15.3.5.2 Business Overview
15.3.5.3 Financial Overview
15.3.5.4 SWOT Analysis
15.3.5.5 Strategic Overview
15.3.6. F. Hoffmann-La Roche Ltd.
15.3.6.1 Company Overview
15.3.6.2 Business Overview
15.3.6.3 Financial Overview
15.3.6.4 SWOT Analysis
15.3.6.5 Strategic Overview
15.3.7. QIAGEN N.V.
15.3.7.1 Company Overview
15.3.7.2 Business Overview
15.3.7.3 Financial Overview
15.3.7.4 SWOT Analysis
15.3.7.5 Strategic Overview
15.3.8. Siemens AG
15.3.8.1 Company Overview
15.3.8.2 Business Overview
15.3.8.3 Financial Overview
15.3.8.4 SWOT Analysis
15.3.8.5 Strategic Overview
15.3.9. Thermo Fisher Scientific Inc.
15.3.9.1 Company Overview
15.3.9.2 Business Overview
15.3.9.3 Financial Overview
15.3.9.4 SWOT Analysis
15.3.9.5 Strategic Overview

Table 1: Global Molecular Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2015–2025 
Table 2: Global Molecular Diagnostics Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 3: Global Molecular Diagnostics Market Size (US$ Mn) Forecast, by Infectious Diseases, 2015–2025
Table 4: Global Molecular Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 5: Global Molecular Diagnostics Market Size (US$ Mn) Forecast, by Region, 2015–2025
Table 06: North America Molecular Diagnostics Market Size (US$ Mn) Forecast, by Technology Type, 2015–2025
Table 07: North America Molecular Diagnostics Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 08: North America Molecular Diagnostics Market Size (US$ Mn) Forecast, by Infectious Diseases, 2015–2025
Table 09: North America Molecular Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 10: North America Molecular Diagnostics Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 11: Europe Molecular Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2015–2025
Table 12: Europe Molecular Diagnostics Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 13: Europe Molecular Diagnostics Market Size (US$ Mn) Forecast, by Infectious Diseases, 2015–2025
Table 14: Europe Molecular Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 15: Europe Molecular Diagnostics Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 16: Asia Pacific Molecular Diagnostics Market Size (US$ Mn) Forecast, by Technology Type, 2015–2025
Table 17: Asia Pacific Molecular Diagnostics Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 18: Asia Pacific Molecular Diagnostics Market Size (US$ Mn) Forecast, by Infectious Diseases, 2015–2025
Table 19: Asia Pacific Molecular Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 20: Asia Pacific Molecular Diagnostics Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 21: Latin America Molecular Diagnostics Market Size (US$ Mn) Forecast, by Technology Type, 2015–2025
Table 22: Latin America Molecular Diagnostics Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 23: Latin America Molecular Diagnostics Market Size (US$ Mn) Forecast, by Infectious Diseases, 2015–2025
Table 24: Latin America Molecular Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 25: Latin America Molecular Diagnostics Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 26: Middle East & Africa Molecular Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2015–2025
Table 27: Middle East & Africa Molecular Diagnostics Market Size (US$ Mn) Forecast, By Application, 2015–2025
Table 28: Middle East & Africa Molecular Diagnostics Market Size (US$ Mn) Forecast, By Infectious Diseases, 2015–2025
Table 29: Middle East & Africa Molecular Diagnostics Market Size (US$ Mn) Forecast, By End User, 2015–2025
Table 30: Middle East & Africa Molecular Diagnostics Market Size (US$ Mn) Forecast, by Country, 2015–2025

Figure 1: Global Molecular Diagnostic Market Size (US$ Mn) Forecast, 2015–2025
Figure 2: Global Molecular Diagnostics Market Value Share, by Technology (2017)
Figure 3: Global Molecular Diagnostics Market Value Share, by Application (2017)
Figure 4: Global Molecular Diagnostics Market Value Share, by Region (2017)
Figure 5: Global Molecular Diagnostics Market Value Share, by End-user (2017)
Figure 6: Global Molecular Diagnostic Market Value Share Analysis, by Technology, 2017 and 2025
Figure 7: Global Molecular Diagnostic Market Attractiveness Analysis, by Technology, 2016
Figure 8: Global PCR and Real-Time PCR Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 9: Global Hybridization Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 10: Global Microarray Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 11: Global Transcription-Mediated Amplification Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 12: Global Next-Generation Sequencing Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 13: Global Others (Mass Spectrometry etc.) Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 14: Global Molecular Diagnostics Market Value Share Analysis, by Application, 2017 and 2025
Figure 15: Global Molecular Diagnostics Market Attractiveness Analysis, by Application, 2016
Figure 16: Global Infectious Diseases Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 17: Global Oncology Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 18: Global Blood Screening Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 19: Global Microbiology Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 20: Global Genetic Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 21: Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 22: Global Molecular Diagnostic Market Value Share Analysis, by End-user, 2017 and 2025
Figure 23: Global Molecular Diagnostic Market Attractiveness Analysis, by End-user, 2016
Figure 24: Global Hospital Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 25: Global Diagnostic Laboratories Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 26: Global Blood Banks Centers Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 27: Global Academics & Research Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 28: Global Others Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 29: Global Molecular Diagnostics Market Value Share Analysis, by Region, 2017 and 2025
Figure 30: Global Molecular Diagnostics Market Attractiveness Analysis, by Region, 2016
Figure 31: North America Molecular Diagnostics Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 32: North America Molecular Diagnostics Market Attractiveness Analysis, by Country, 2016
Figure 33: North America Market Value Share Analysis, by Technology Type, 2017 and 2025
Figure 34: North America Market Value Share Analysis, by Application, 2017 and 2025
Figure 35: North America Market Value Share Analysis, by End-user, 2017 and 2025
Figure 36: North America Market Value Share Analysis, by Country, 2017 and 2025
Figure 37: North America Market Attractiveness Analysis, by Technology
Figure 38: North America Market Attractiveness Analysis, by Application
Figure 39: North America Market Attractiveness Analysis, by End-user
Figure 40: Europe Molecular Diagnostics Market Size (US$ Mn) Forecast, 2015–2025
Figure 41: Europe Molecular Diagnostics Market Attractiveness Analysis, by Country, 2016
Figure 42: Europe Molecular Diagnostics Market Value Share Analysis, by Technology, 2017 and 2025
Figure 43: Europe Molecular Diagnostics Market Value Share Analysis, by Application, 2017 and 2025
Figure 44: Europe Molecular Diagnostics Market Value Share Analysis, by End-user, 2017 and 2025
Figure 45: Europe Molecular Diagnostics Market Value Share Analysis, by Country, 2017 and 2025
Figure 46: Europe Molecular Diagnostics Market Attractiveness Analysis, by Technology
Figure 47: Europe Molecular Diagnostics Market Attractiveness Analysis, by Application
Figure 48: Europe Molecular Diagnostics Market Attractiveness Analysis, by End-user
Figure 49: Asia Pacific Molecular Diagnostics Market Size (US$ Mn) Forecast, 2015–2025
Figure 50: Asia Pacific Molecular Diagnostics Market Attractiveness Analysis, by Country, 2016
Figure 51: Asia Pacific Market Value Share Analysis, by Technology Type, 2017 and 2025
Figure 52: Asia Pacific Market Value Share Analysis, by Application, 2017 and 2025
Figure 53: Asia Pacific Market Value Share Analysis, by End-user, 2017 and 2025
Figure 54: Asia Pacific Market Value Share Analysis, by Country, 2017 and 2025
Figure 55: Asia Pacific Market Attractiveness Analysis, by Technology
Figure 56: Asia Pacific Market Attractiveness Analysis, by Application
Figure 57: Asia Pacific Market Attractiveness Analysis, by End-user
Figure 58: Latin America Molecular Diagnostics Market Size (US$ Mn) Forecast, 2015–2025
Figure 59: Latin America Molecular Diagnostics Market Attractiveness Analysis, by Country, 2016
Figure 60: Latin America Market Value Share Analysis, by Technology Type, 2017 and 2025
Figure 61: Latin America Market Value Share Analysis, by Application, 2017 and 2025
Figure 62: Latin America Market Value Share Analysis, by End-user, 2017 and 2025
Figure 63: Latin America Market Value Share Analysis, by Country, 2017 and 2025
Figure 64: Latin America Market Attractiveness Analysis, by Technology
Figure 65: Latin America Market Attractiveness Analysis, by Application
Figure 66: Latin America Market Attractiveness Analysis, by End-user
Figure 67: Middle East & Africa Molecular Diagnostics Market Size (US$ Mn) Forecast, 2015–2025
Figure 68: Middle East & Africa Molecular Diagnostics Market Attractiveness Analysis By Country, 2016
Figure 69: Middle East & Africa Market Value Share Analysis, by Technology Type, 2017 and 2025
Figure 70: Middle East & Africa Market Value Share Analysis, by Application, 2017 and 2025
Figure 71: Middle East & Africa Market Value Share Analysis, by End User, 2017 and 2025
Figure 72: Middle East & Africa Market Value Share Analysis, by Country, 2017 and 2025
Figure 73: Middle East & Africa Market Attractiveness Analysis, by Technology
Figure 74: Middle East & Africa Market Attractiveness Analysis, by Application
Figure 75: Middle East & Africa Market Attractiveness Analysis, by End User
Figure 76: Global Molecular Diagnostics Market Share Analysis, by Company